Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's letter to the editor re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association between lead time and prostate cancer grade: Evidence of grade progression from long-term follow-up of large population-based cohorts not subject to prostate-specific antigen screening. Eur Urol 2018;73:961–7 Correspondence

  

Authors:	Vickers, A. J.; Lilja, H.; Assel, M.
Title:	Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's letter to the editor re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association between lead time and prostate cancer grade: Evidence of grade progression from long-term follow-up of large population-based cohorts not subject to prostate-specific antigen screening. Eur Urol 2018;73:961–7
Keywords:	cancer growth; follow up; cancer diagnosis; letter; prostate specific antigen; cancer screening; prostate cancer; gleason score; long term survival; human; priority journal
Journal Title:	European Urology
Volume:	75
Issue:	3
ISSN:	0302-2838
Publisher:	Elsevier Science, Inc.
Date Published:	2019-03-01
Start Page:	e56
Language:	English
DOI:	10.1016/j.eururo.2018.10.003
PUBMED:	30327273
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060678211&doi=10.1016%2fj.eururo.2018.10.003&partnerID=40&md5=bf2824dc60fa315a574476c48e40c916
Notes:	Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/142617